Bioxcel Therapeutics Share | Buy US Stock from India on Kuvera

Q: Can I buy Bioxcel Therapeutics shares in India?

<div>Kuvera makes it super convenient to trade in US Stocks from India. You can buy / sell Bioxcel Therapeutics stocks after a simple registration process. </div>

Q: How to buy Bioxcel Therapeutics shares in India?

<div> To buy Bioxcel Therapeutics shares from India, just follow these simple steps: <div>Step 1: Login to the Kuvera app or website and go to US Stocks.</div> <div>Step 2: Link your existing Vested US investing account, or create a new one.</div> <div>Step 3: Complete all the KYC process and fund your US Stock trading account.</div> <div>Step 4: Place buy order for Bioxcel Therapeutics and you are done!</div> </div>

Q: What is the share price of Bioxcel Therapeutics?

<div>The share price of Bioxcel Therapeutics is USD 0.48 as on 9 Dec.</div>

Q: What is the Market Capitalization of Bioxcel Therapeutics?

<div>Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Bioxcel Therapeutics is USD 23.21M as on 9 Dec.</div>

Q: What is the PE ratio of Bioxcel Therapeutics?

<div> The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is overvalued in relation to the earnings (revenue) generated. PE ratio of Bioxcel Therapeutics is N/A as on 9 Dec. </div>

Q: Is Bioxcel Therapeutics a good stock to buy?

<div>Kuvera provides relevant fundamental details of Bioxcel Therapeutics to help you evaluate. We also recommend you do thorough research before making an investment decision.</div>

Q: In which sector / industry does Bioxcel Therapeutics operate?

<div> Bioxcel Therapeutics operates in Healthcare / Biotechnology

Healthcare Biotechnology

$0.48

+0.07

(9 Dec)

Loading Chart

Previous close

$0.48

Open

$0.48

Today’s high

$0.56

Today’s low

$0.44

52W low

$0.36

52W high

$4.17

-84.70%

-39.94%

EPS (TTM)

-1.94

Shares O/S

48.35M

Market cap

23.21M

Insights

BTAI has made a new 52 Wk low. 52 Wk low stocks tend to underperform in the near term.

BTAI price is below its 200 day moving average

BTAI is in the lowest 10% returns in the past year. It is a low momentum stock. Low momentum stocks tend to underperform in the near term.

In beta. Send feedback here.

Compare with other stock

About Bioxcel Therapeutics

BioXcel Therapeutics, Inc. is a biopharmaceutical company utilizing artificial intelligence to develop medicines in neuroscience. Its subsidiary, OnkosXcel Therapeutics, develops medicines in immuno-oncology. The Company’s most advanced neuroscience candidate, BXCL501, is an investigational, proprietary, orally dissolving film formulation of Dex in development for the treatment of agitation associated with psychiatric and neurological disorders.

It is continuing to develop BXCL501 for the potential acute treatment of agitation associated with bipolar disorders or schizophrenia in the at-home setting and for the potential acute treatment of agitation (non-daily) associated with dementia due to probable Alzheimers disease in the at-home setting and in care facilities. Its most advanced immuno-oncology candidate, BXCL701, is an investigational oral innate immune activator for the treatment of aggressive forms of prostate cancer, pancreatic cancer, and other solid and liquid tumors. .

FAQs

Can I buy Bioxcel Therapeutics shares in India?

How to buy Bioxcel Therapeutics shares in India?

What is the share price of Bioxcel Therapeutics?

What is the Market Capitalization of Bioxcel Therapeutics?

What is the PE ratio of Bioxcel Therapeutics?

Is Bioxcel Therapeutics a good stock to buy?

In which sector / industry does Bioxcel Therapeutics operate?